Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis

Journal of Clinical Microbiology

Volumn 41, Issue 4, 2003, Pages 1357-1362

  Borst, A ^a,d   Theelen, B ^b   Reinders, E ^c   Boekhout, T ^b   Fluit, A C ^a   Savelkoul, P H M ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; DATA BASE; DRUG RESISTANCE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; MORTALITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

CANDIDA; CANDIDIASIS; DNA, FUNGAL; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SPECIES SPECIFICITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGI;

EID: 12444309299     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.4.1357-1362.2003     Document Type: Article

References (35)

1. Abi Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24:1122-1128.
2. Baumgartner, C., A.-M. Freydiere, and Y. Gille. 1996. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J. Clin. Microbiol. 34:454-456.
3. Bernal, S., M. E. Martin, M. Chavez, J. Coronilla, and A. Valverde. 1998. Evaluation of the new API Candida system for identification of the most clinically important yeast species. Diagn. Microbiol. Infect. Dis. 32:217-221.
4. Blignaut, E., C. Pujol, S. Lockhart, S. Joly, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa. J. Clin. Microbiol. 40:826-836.
5. Campbell, C. K., K. G. Davey, A. D. Holmes, A. Szekely, and D. W. Warnock. 1999. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J. Clin. Microbiol. 37:821-823.
6. Donnelly, S. M., D. J. Sullivan, D. B. Shanley, and D. C. Coleman. 1999. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871-1882.
7. Elie, C. M., T. J. Lott, E. Reiss, and C. J. Morrison. 1998. Rapid identification of Candida species with species-specific DNA probes. J. Clin. Microbiol. 36:3260-3265.
8. Espinel-Ingrolf, A., L. Stockman, G. Roberts, D. Pincus, J. Pollack, and J. Marler. 1998. Comparison of RapID Yeast Plus System with API 20C system for identification of common, new, and emerging yeast pathogens. J. Clin. Microbiol. 36:883-886.
9. Gee, S. F., S. Joly, D. R. Soll, J. F. G. M. Meis, P. E. Verweij, I. Polacheck D. J. Sullivan, and D. C. Coleman. 2002. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo, J. Clin. Microbiol. 40:556-574.
10. Giamarellou, H., and A. Antoniadou. 1996. Epidemiology, diagnosis, and therapy of fungal infections in surgery. Infect. Control Hosp. Epidemiol. 17:558-564.
11. Gumbo, T., C. M. Isada, G. Hall, M. T. Karafa, and S. M. Gordon. 1999. Candida glabrata fungemia. Clinical features of 139 patients. Medicine (Baltimore) 78:220-227.
12. Hoppe, J. E., and P. Frey. 1999. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 18:188-191.
13. Jones, C. J., K. J. Edwards, S. Castaglione, M. O. Winfield, F. Sala, C. VandeWiel, G. Bredemeijer, B. Vosman, M. Matthes, A. Daly, R. Brettschneider, P. Bettini, M. Buiatti, E. Maestri, A. Malcevschi, N. Marmiroli, R. Aert, G. Volckaert, J. Rueda, R. Linacero, A. Vazquez, and A. Karp. 1997. Reproducibility testing of RAPD, AFLP and SSR markers in plants by a network of European laboratories. Mol. Breed. 3:381-390.
14. Kao, A. S., M. E. Brandt, W. R. Pruitt, L. A. Conn, B. A. Perkins, D. S. Stephens, W. S. Baughman, A. L. Reingold, G. A. Rothrock, M. A. Pfaller, R. W. Pinner, and R. A. Hajjeh. 1999. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance, Clin. Infect. Dis. 29:1164-1170.
15. Kirkpatrick, W. R., S. G. Revankar, R. K. Mcatee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
16. Kurzai, O., W. J. Heinz, D. J. Sullivan, D. C. Coleman, M. Frosch, and F. A. Mühlschlegel. 1999. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J. Clin. Microbiol. 37:1587-1590.
17. Kurzai, O., H. C. Korting, D. Harmsen, W. Bautsch, M. Molitor, M. Frosch, and F. A. Muhlschlegel. 2000. Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J. Mol. Med. 78:521-529.
18. Lott, T. J., and M. M. Effat. 2001. Evidence for a more recently evolved clade within a Candida albicans North American population. Microbiology 147:1687-1692.
19. Martin, C., D. Roberts, M. van der Weide, R. Rossau, G. Jannes, T. Smith, and M. Maher. 2000. Development of a PCR-based line probe assay for identification of fungal pathogens. J. Clin. Microbiol. 38:3735-3742.
20. McIlhatton, B. P., C. Keating, M. D. Curran, M. F. McMullin, J. G. Barr, J. A. Madrigal, and D. Middleton. 2002. Identification of medically important pathogenic fungi by reference strand-mediated conformational analysis (RSCA). J. Med. Microbiol. 51:468-478.
21. Meyer, W., K. Maszewska, and T. C. Sorrell. 2001. PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med. Mycol. 39:185-193.
22. Moran, G. P., D. Sanglard, S. M. Donnelly, D. B. Shanley, D. J. Sullivan, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830.
23. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
24. Odds, F. C., and A. Davidson. 2000. "Room temperature" use of CHROMagar Candida. Diagn. Microbiol. Infect. Dis. 38:147-150.
25. Park, S., M. Wong, S. A. E. Marras, E. W. Cross, T. E. Kiehn, V. Chaturvedi, S. Tyagi, and D. S. Perlin. 2000. Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J. Clin. Microbiol. 38:2829-2836.
26. Pfaller, M. A., R. N. Jones, G. V. Doern, A. C. Fluit, J. Verhoef, H. S. Sader, S. A. Messer, A. Houston, S. Coffman, R. J. Hollis, et al. 1999. International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn. Microbiol. Infect. Dis. 35:19-25.
27. Pittet, D., N. Li, and R. P. Wenzel. 1993. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur. J. Clin. Microbiol. Infect. Dis. 12:813-819.
28. Pujol, C., S. Joly, S. R. Lockhart, S. Noel, M. Tibayrenc, and D. R. Soll. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35:2348-2358.
29. Savelkoul, P. H. M., H. J. M. Aarts, J. de Haas, L. Dijkshoorn, B. Duim, M. Otsen, J. L. W. Rademaker, L. Schouls, and J. A. Lenstra. 1999. Amplified-fragment length polymorphism analysis: the state of an art. J. Clin. Microbiol. 37:3083-3091.
30. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
31. Tintelnot, K., G. Haase, M. Seibold, F. Bergmann, M. Staemmler, T. Franz, and D. Naumann. 2000. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J. Clin. Microbiol. 38:1599-1608.
32. Vos, P., R. Hogers, M. Bleeker, M. Reijans, T. Van de Lee, M. Hornes, A. Frijters, J. Pot, J. Peleman, M. Kuiper, and M. Zabeau. 1995. AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 23:4407-4414.
33. Wenzel, R. P. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20:1531-1534.
34. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645.
35. Willinger, B., C. Hillowoth, B. Selitsch, and M. Manafi. 2001. Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J. Clin. Microbiol. 39:3793-3795.